Cargando…
996. The Potential for Reducing Opioid and Analgesic Prescriptions Via Herpes Zoster Vaccination
BACKGROUND: Herpes zoster (HZ), or shingles, is a common neurocutaneous disease caused by the reactivation of latent varicella zoster virus that often includes rash and neuropathic pain that may last for months. Opioids and other analgesics may be prescribed. Recombinant zoster vaccine (RZV) is pref...
Autores principales: | Poirrier, Jean-Etienne, Carrico, Justin, DeMartino, Jessica K, Hicks, Katherine A, Stoddard, Jeffrey J, Nagar, Saurabh P, Meyers, Juliana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776142/ http://dx.doi.org/10.1093/ofid/ofaa439.1182 |
Ejemplares similares
-
Burden of opioid use for pain management among adult herpes zoster patients in the US and the potential impact of vaccination
por: Poirrier, Jean-Etienne, et al.
Publicado: (2022) -
Herpes Zoster Incidence and Burden in Adults With Type 2 Diabetes in the U.S.: A Retrospective Database Analysis
por: Poirrier, Jean-Etienne, et al.
Publicado: (2022) -
20. Cost-Effectiveness of Recombinant Zoster Vaccine for Vaccinating Immunocompromised Adults Against Herpes Zoster in the United States
por: Curran, Desmond, et al.
Publicado: (2021) -
Public health impact of recombinant zoster vaccine for prevention of herpes zoster in US adults immunocompromised due to cancer
por: Curran, Desmond, et al.
Publicado: (2023) -
Impact of population aging on the burden of vaccine-preventable diseases among older adults in the United States
por: Talbird, Sandra E, et al.
Publicado: (2020)